Johnson & Johnson (NYSE:JNJ) declared a quarterly dividend on Monday, July 17th, RTT News reports. Investors of record on Tuesday, August 29th will be given a dividend of 0.84 per share on Tuesday, September 12th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.53%. The ex-dividend date of this dividend is Friday, August 25th.

Johnson & Johnson has raised its dividend payment by an average of 6.7% annually over the last three years and has increased its dividend every year for the last 54 years. Johnson & Johnson has a dividend payout ratio of 47.3% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Johnson & Johnson to earn $7.72 per share next year, which means the company should continue to be able to cover its $3.36 annual dividend with an expected future payout ratio of 43.5%.

Johnson & Johnson (JNJ) traded down 0.48% on Monday, hitting $131.97. 915,752 shares of the company were exchanged. The company has a 50 day moving average price of $130.42 and a 200-day moving average price of $122.68. The stock has a market capitalization of $355.51 billion, a P/E ratio of 22.18 and a beta of 0.78. Johnson & Johnson has a 52 week low of $109.32 and a 52 week high of $137.00.

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings data on Tuesday, April 18th. The company reported $1.83 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.77 by $0.06. Johnson & Johnson had a net margin of 22.87% and a return on equity of 26.50%. The company had revenue of $17.77 billion for the quarter, compared to the consensus estimate of $18.02 billion. During the same period in the prior year, the firm posted $1.68 EPS. Johnson & Johnson’s revenue for the quarter was up 1.6% on a year-over-year basis. On average, equities analysts expect that Johnson & Johnson will post $7.10 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This story was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this story can be viewed at

Several equities analysts have issued reports on the stock. Vetr cut shares of Johnson & Johnson from a “buy” rating to a “hold” rating and set a $128.90 target price on the stock. in a research note on Monday, May 8th. Wells Fargo & Company restated a “market perform” rating and set a $135.00 target price (up previously from $132.00) on shares of Johnson & Johnson in a research note on Thursday, July 6th. UBS AG restated a “buy” rating and set a $136.00 target price on shares of Johnson & Johnson in a research note on Monday, May 15th. J P Morgan Chase & Co upgraded shares of Johnson & Johnson from a “neutral” rating to an “overweight” rating and upped their target price for the company from $123.64 to $140.00 in a research note on Monday, May 15th. Finally, BidaskClub cut shares of Johnson & Johnson from a “strong-buy” rating to a “buy” rating in a research note on Saturday, July 1st. Eleven research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $133.65.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Dividend History for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with's FREE daily email newsletter.